Clinical evaluation of the combination of anorganic bovine-derived hydroxyapatite matrix/cell-binding peptide (P-15) in particulate and hydrogel form as a bone replacement graft material in human periodontal osseous defects: 6-month reentry controlled clinical study

Journal of Periodontology

Volumn 78, Issue 10, 2007, Pages 1855-1863

  Matos, Sérgio M ^a   Guerra, Fernando A ^a   Krauser, Jack ^b   Marques, Francisco ^a   Ermida, Jorge M ^a   Sanz, Mariano ^c  

^a UNIVERSITY OF COIMBRA   (Portugal)

^b University Complutense of Madrid ^*

^c UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

Hydrogel; Hydroxyapatite therapeutic use; Periodontal diseases therapy; Regeneration

Indexed keywords

CARBOXYMETHYLCELLULOSE; CELL BINDING PEPTIDE P 15; CELL-BINDING PEPTIDE P-15; COLLAGEN; GLYCEROL; HYDROXYAPATITE; PEPTIDE FRAGMENT;

ADULT; ALVEOLAR BONE LOSS; ANIMAL; ARTICLE; BONE PROSTHESIS; BONE REGENERATION; CATTLE; CHEMISTRY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; HYDROGEL; MALE; METHODOLOGY; MIDDLE AGED; ORAL SURGERY; PARTICLE SIZE; PERIODONTITIS; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ADULT; ALVEOLAR BONE LOSS; ANIMALS; BONE REGENERATION; BONE SUBSTITUTES; CARBOXYMETHYLCELLULOSE SODIUM; CATTLE; COLLAGEN; FEMALE; GLYCEROL; HUMANS; HYDROGELS; HYDROXYAPATITES; MALE; MIDDLE AGED; ORAL SURGICAL PROCEDURES; PARTICLE SIZE; PEPTIDE FRAGMENTS; PERIODONTITIS; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 35648994859     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2007.060474     Document Type: Article

References (33)

1. Sculean A, Berakdar M, Chiantella GC, Donos N, Arweiler NB, Brecx M. Healing of intrabony defects following treatment with a bovine-derived xenograft and collagen membrane. J Clin Periodontal 2003;30:73-80.
2. Cortellini P, Tonetti MS. Focus on intrabony defects: Guided tissue regeneration. Periodontol 2000 2000;22: 104-132.
3. Trombelli L, Heitz-Mayfield JA, Needleman IG, Scabbia A, Moles DR. A systematic review of graft materials and biological agents for periodontal intraosseous defects. J Clin Periodontol 2002;29(Suppl, 3):117-135.
4. Reynolds MA, Aichelmann-Reidy ME, Branch-Mays GL, Gunsolley JC. The efficacy of bone replacement grafts in the treatment of periodontal osseous defects. A systematic review. Ann Periodontol 2003;8:227-265.
5. Bhatnagar RS, Qiang JJ, Wedrychowska AW, Sadeghi M, Mu YM, Smith N. Design of biomimetic habitats for tissue engineering with P-15, a synthetic peptide analogue of collagen. Tissue Eng 1999;5:53-65.
6. Camelo M, Nevins M, Lynch S, Schenk RK, Simion M, Nevins M. Periodontal regeneration with an autogenous bone Bio-Oss composite graft and a Bio-Gide membrane. Int J Periodontics Restorative Dent 2001;21:109-119.
7. Nevins ML, Camelo M, Lynch S, Schenk R, Nevins M. Evaluation of periodontal regeneration following grafting intrabony defects with Bio-Oss collagen: A human histologic report. Int J Periodontics Restoratiue Dent 2003;23:9-17.
8. Mellonig JT. Human histologic evaluation of a bovinederived bone xenograft in the treatment of periodontal osseous defects. Int J Periodontics Restorative Dent 2000;20:19-29.
9. Yukna RA, Salinas TJ, Carr RF. Periodontal regeneration following use of ABM/P-15: A case report. Int J Periodontics Restorative Dent 2002;22:146-155.
10. Callan DP, Rohrer MD. Use of natural hydroxyapatite in the repair of edentulous ridge defects. A human clinical and histologic case report. J Periodontol 1993;64:575-582.
11. Zaner DJ, Yukna RA. Particle size of periodontal bone grafting materials. J Periodontol 1984;55:406-409.
12. Yukna RA, Callan DP, Krauser JT, et al. Multi-center clinical evaluation of combination anorganic bovinederived hydroxylapatite matrix (ABM)/cell binding peptide (P-15) as a bone replacement graft material in human periodontal osseous defects. 6-month results. J Periodontol 1998;69:655-663.
13. Yukna RA, Krauser JT, Callan DP, Evans GH, Cruz R, Martin M. Multi-center clinical comparison of combination anorganic bovine-derived hydroxylapatite matrix (ABM)/cell binding peptide (P-15) and ABM in human periodontal osseous defects. 6-month results. J Periodontol 2000;71:1671-1679.
14. Yukna RA, Krauser JT, Callan DP, Evans GH, Cruz R, Martin M. Thirty-six month follow-up of 25 patients treated with combination anorganic bovine-derived hydroxyapatite matrix (ABM)/cell binding peptide (P-15) bone replacement grafts in human infrabony defects. J Periodontol 2002;73:123-128.
15. Turesky S, Gilmore ND, Glickman I. Reduced plaque formation by the chlorometyl analogue of vitamin C. J Periodontol 1970;41:41-43.
16. Lobene RR, Weatherford T, Ross NM, Lamm RA, Menaker L. A modified gingival index for use in clinical trials. Clin Prev Dent 1986;8:3-6.
17. Needleman I, Tucker R, Giedrys-Leeper E, Worthington H. Guided tissue regeneration for periodontal intrabony defects - A Cochrane Systematic Review. Periodontol 2000 2005;37:106-123.
18. Gunsolley JC, Elswick RK, Davenport JM. Equivalence and superiority testing in regeneration clinical trials. J Periodontol 1998;69:521-527.
19. Scheyer ET, Velasquez-Plata D, Brunsvold MA, Lasho DJ, Mellonig JT. A clinical comparison of a bovine-derived xenograft used alone and in combination with enamel matrix derivative for the treatment of periodontal osseous defects in humans. J Periodontol 2002;73:423-432.
20. Camargo PM, Lekovic V, Weinlaender M, et al. A controlled re-entry study on the effectiveness of bovine porous bone mineral used in combination with a collagen membrane of porcine origin in the treatment of intrabony defects in humans. J Clin Periodontol 2000;27:889-896.
21. Lekovic V, Camargo PM, Weinlaender M, Vasilic N, Djordjevic M, Kenney EB. The use of bovine porous bone mineral in combination with enamel matrix proteins or with an autologous fibrinogen/fibronectin system in the treatment of intrabony defects in humans. J Periodontol 2001;72:1157-1163.
22. Richardson CR, Mellonig JT, Brunsvold MA, McDonnel HT, Cochran DL. Clinical evaluation of Bio-Oss: A bovine-derived xenograft for the treatment of periodontal osseous defects in humans. J Clin Periodontol 1999;26:421-428.
23. Schulz A, Hilgers RD, Niedermeier W. The effect of splinting of teeth in combination with reconstructive periodontal surgery in humans. Clin Oral Investig 2000; 4:98-105.
24. Kenney EB, Lekovic V, Han T, Carranza FA, Dimitrijevic B. The use of a porous hydroxylapatite implant in periodontal defects. I. Clinical results after six months. J Periodontol 1985;56:82-88.
25. Mora F, Ouhayoun JP. Clinical evaluation of natural coral and porous hydroxyapatite implants in periodontal bone lesions: Results of a 1-year follow-up. J Clin Periodontol 1995;22:877-884.
26. Yukna RA. Clinical evaluation of coralline calcium carbonate as a bone replacement graft material in human periodontal osseous defects. J Periodontol 1994; 65:177-185.
27. Cortellini P, Carnevale G, Sanz M, Tonetti MS. Treatment of deep and shallow intrabony defects. A multicenter randomized controlled clinical trial. J Clin Periodontol 1998;25:981-987.
28. Tonetti MS, Cortellini P, Lang NP, et al. Clinical outcomes following treatment of human intrabony defects with GTR/bone replacement material or access flap alone. A multicenter randomized controlled clinical trial. J Clin Periodontol 2004;31: 770-776.
29. Zucchelli G, Amore C, Montebugnoli L, Sanctis M. Enamel matrix proteins and bovine porous bone mineral in the treatment of intrabony defects: A comparative controlled clinical trial. J Periodontol 2003; 74:1725-1735.
30. Hahn J, Rohrer MD, Tofe AJ. Clinical, radiographic, histologic and histomorphometric comparison of PepGen P-15 flow in extraction sockets: A same-mouth case study. Implant Dent 2003;12:170-174.
31. Vastardis S, Yukna RA, Mayer ET, Atkinson BL. Periodontal regeneration with peptide-enhanced anorganic bone matrix in particulate and putty form in dogs. J Periodontol 2005;76:1690-1696.
32. Scarano A, Iezzi G, Petrone G, et al. Cortical bone regeneration with a synthetic cell-binding peptide: A histologic and histomorphometric pilot study. Implant Dent 2003;12:318-324.
33. Nguyen H, Qian JJ, Bhatnagar RS, Li S. Enhanced cell attachment and osteoblastic activity by P-15 peptidecoated matrix in hydrogels. Blochem Biophys Res Commun 2003;311:179-186.